GLG Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$54K Buy
+880
New +$54.4K ﹤0.01% 445
2016
Q1
Sell
-89,108
Closed -$7.96M 418
2015
Q4
$7.96M Sell
89,108
-194,987
-69% -$16.6M 0.25% 105
2015
Q3
$21.8M Buy
284,095
+3,534
+1% +$295K 0.58% 49
2015
Q2
$23.5M Buy
280,561
+2,363
+0.8% +$209K 0.61% 42
2015
Q1
$25.1M Sell
278,198
-392,500
-59% -$33.8M 0.84% 31
2014
Q4
$54.1M Buy
670,698
+513,355
+326% +$40.5M 1.58% 10
2014
Q3
$11.8M Buy
157,343
+23,143
+17% +$1.68M 0.27% 112
2014
Q2
$9.2M Sell
134,200
-32,739
-20% -$2.23M 0.22% 126
2014
Q1
$11.7M Buy
+166,939
New +$11.6M 0.23% 123

Other funds holding CAH

GLG Partners's CAH Position: Q4 2017 in Review

GLG Partners opened a new position in Cardinal Health (CAH) in Q4 2017: 880 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #445 among its holdings. This is a return to the name: GLG Partners previously reported a position in CAH as recently as Q4 2015.

GLG Partners first reported a position in CAH in Q1 2014 and has held it in 9 quarters since. The position peaked at $54.1M in Q4 2014. 722 funds tracked by Wall St. Rank hold CAH as of Q4 2017.

  • GLG Partners held 880 shares of Cardinal Health worth $54K as of Q4 2017.
  • Cardinal Health was a new GLG Partners position in Q4 2017.
  • Cardinal Health made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #445 holding.
  • GLG Partners first reported a position in Cardinal Health in Q1 2014 and has held it in 9 quarters since.
  • GLG Partners's Cardinal Health position peaked at $54.1M in Q4 2014.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.